New Search

If you are not happy with the results below please do another search

1271 search results for:

124

EUROIMMUN introduces two new automation solutions for molecular diagnostics

EUROIMMUN introduces two new automation solutions for molecular diagnostics Molecular diagnostic analyses using EUROArray tests can now be completely automated with the introduction of two new devices. The Automated Workstation Pre-NAT II provides fully automated sample preparation, encompassing nucleic acid extraction using proven magneticparticle technology and PCR pipetting. Up to 96 primary samples from various […]

128

TransCure bioServices delivers CDX mouse models to advance AML preclinical studies

TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukaemia (AML). These models enable deeper insights into the efficacy and toxicity of AML therapies, leading to the development of better treatments and bringing hope to the thousands of […]

129

PerkinElmer launches fast, sensitive EnVison Nexus multimode plate reader

PerkinElmer has launched the EnVision Nexus system, its fastest and most sensitive multimode plate reader to date, designed for demanding high-throughput screening (HTS) applications and to accelerate drug discovery efforts. The EnVision Nexus platform, with complementary microplates and optimized reagents from PerkinElmer’s drug discovery reagents portfolio, including proprietary HTRF and AlphaLISA technologies and latest reagent […]

130

FDA clears ‘Selux NGP System’ for rapid Antibiotic Susceptibility Testing

Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary Next Generation Phenotyping (NGP) System – a rapid antibiotic susceptibility (AST) testing platform that provides targeted therapeutic results days faster than the […]